A Study to Investigate the Safety, Tolerability and Pharmacokinetics of RD01 (Pegerythropoietin) in Healthy Chinese Volunteers
Clinical trial NCT03657238 · COMPLETED
Trial details
- NCT number
- NCT03657238
- Sponsor
- Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-08
- Primary completion
- 2019-08-02
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.